» Articles » PMID: 18363565

Integrin Activation

Overview
Specialty Biochemistry
Date 2008 Mar 28
PMID 18363565
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Agonist stimulation of integrin receptors, composed of transmembrane alpha and beta subunits, leads cells to regulate integrin affinity ('activation'), a process that controls cell adhesion and migration, and extracellular matrix assembly. A final step in integrin activation is the binding of talin to integrin beta cytoplasmic domains. We used forward, reverse and synthetic genetics to engineer and order integrin activation pathways of a prototypic integrin, platelet alphaIIbbeta3. PMA activated alphaIIbbeta3 only after expression of both PKCalpha (protein kinase Calpha) and talin at levels approximating those in platelets. Inhibition of Rap1 GTPase reduced alphaIIbbeta3 activation, whereas expression of constitutively active Rap1A(G12V) bypassed the requirement for PKCalpha. Overexpression of a Rap effector, RIAM (Rap1-GTP-interacting adaptor molecule), activated alphaIIbbeta3 and bypassed the requirement for PKCalpha and Rap1. In addition, shRNA (short hairpin RNA)-mediated knockdown of RIAM blocked talin interaction with and activation of integrin alphaIIbbeta3. Rap1 activation caused the formation of an 'activation complex' containing talin and RIAM that redistributed to the plasma membrane and activated alphaIIbbeta3. The central finding was that this Rap1-induced formation of an 'integrin activation complex' leads to the unmasking of the integrin-binding site on talin, resulting in integrin activation.

Citing Articles

Integrins in Cardiovascular Health and Disease: Molecular Mechanisms and Therapeutic Opportunities.

Lawkowska K, Bonowicz K, Jerka D, Bai Y, Gagat M Biomolecules. 2025; 15(2).

PMID: 40001536 PMC: 11853560. DOI: 10.3390/biom15020233.


The differential formation and composition of leukocyte-platelet aggregates induced by various cellular stimulants.

Peshkova A, Saliakhutdinova S, Sounbuli K, Selivanova Y, Andrianova I, Khabirova A Thromb Res. 2024; 241:109092.

PMID: 39024901 PMC: 11411814. DOI: 10.1016/j.thromres.2024.109092.


Inhibition of talin-induced integrin activation by a double-hit stapled peptide.

Gao T, Cho E, Zhang P, Wu J Structure. 2023; 31(8):948-957.e3.

PMID: 37369205 PMC: 10526925. DOI: 10.1016/j.str.2023.05.016.


Extracellular Matrix Modulates Outgrowth Dynamics in Ovarian Cancer.

Alshehri S, Pavlovic T, Farsinejad S, Behboodi P, Quan L, Centeno D Adv Biol (Weinh). 2022; 6(12):e2200197.

PMID: 36084257 PMC: 9772079. DOI: 10.1002/adbi.202200197.


Timosaponin AIII Suppresses RAP1 Signaling Pathway to Enhance the Inhibitory Effect of Paclitaxel on Nasopharyngeal Carcinoma.

Li X, Lu W, Zhou T, Zhao F, Yang L Comput Math Methods Med. 2022; 2022:6756676.

PMID: 35586672 PMC: 9110172. DOI: 10.1155/2022/6756676.


References
1.
Gottschalk K, Adams P, Brunger A, Kessler H . Transmembrane signal transduction of the alpha(IIb)beta(3) integrin. Protein Sci. 2002; 11(7):1800-12. PMC: 2373644. DOI: 10.1110/ps.4120102. View

2.
Tang P, Cao C, Xu M, Zhang L . Cytoskeletal protein radixin activates integrin alpha(M)beta(2) by binding to its cytoplasmic tail. FEBS Lett. 2007; 581(6):1103-8. DOI: 10.1016/j.febslet.2007.02.013. View

3.
Arnaout M, Mahalingam B, Xiong J . Integrin structure, allostery, and bidirectional signaling. Annu Rev Cell Dev Biol. 2005; 21:381-410. DOI: 10.1146/annurev.cellbio.21.090704.151217. View

4.
Stefansson A, Armulik A, Nilsson I, von Heijne G, Johansson S . Determination of N- and C-terminal borders of the transmembrane domain of integrin subunits. J Biol Chem. 2004; 279(20):21200-5. DOI: 10.1074/jbc.M400771200. View

5.
Jin M, Andricioaei I, Springer T . Conversion between three conformational states of integrin I domains with a C-terminal pull spring studied with molecular dynamics. Structure. 2004; 12(12):2137-47. DOI: 10.1016/j.str.2004.10.005. View